ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LWEL Luckwel Pharmaceuticals Inc (GM)

3.50
0.00 (0.00%)
May 13 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Company Name Stock Ticker Symbol Market Type
Luckwel Pharmaceuticals Inc (GM) LWEL OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 3.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.50 3.50
Trades Volume Avg Volume
0 0.00 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 3.50 USD

Luckwel Pharmaceuticals Inc (GM) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 515.07M 147.16M 14.74M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Luckwel Pharmaceuticals (GM) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LWEL Message Board. Create One! See More Posts on LWEL Message Board See More Message Board Posts

Historical LWEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years8.508.502.003.64413-5.00-58.82%
5 Years4.008.502.003.66350-0.50-12.50%

Luckwel Pharmaceuticals (GM) Description

Luckwel Pharmaceuticals Inc. (OTC:LWEL) is a preclinical-stage, publicly-traded biotechnology company focused on the development and commercialization of innovative therapies in 505(b)(2) & 505(b)(1) strategy.Luckwel creates new possibilities in medicine to cure diseases and improve people's lives by focusing on autoimmune disease, HIV/AIDS, infectious diseases.